Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium

Pharmacological Research

Volumn 56, Issue 2, 2007, Pages 124-131

  Kemeny Beke, Adam ^a   Jakab, Anita ^b   Zsuga, Judit ^b   Vecsernyes, Miklos ^b   Karsai, Denes ^b   Pasztor, Fanni ^b   Grenczer, Maria ^b   Szentmiklosi, Andras Jozsef ^b   Berta, Andras ^a   Gesztelyi, Rudolf ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adenosine deaminase; Atrium; EHNA; Guinea pig; Heart; Pentostatin; Thyroid hormones

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 6 N CYCLOPENTYLADENOSINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE DEAMINASE; CYCLIC GMP; ENZYME INHIBITOR; PENTOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SELECTIVITY; ENZYME INHIBITION; GUINEA PIG; HEART ATRIUM; HYPERTHYROIDISM; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; BENZYL COMPOUNDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUINEA PIGS; HEART ATRIA; HYPERTHYROIDISM; INOSINE; MALE; MYOCARDIAL CONTRACTION; PENTOSTATIN; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RECEPTOR, ADENOSINE A1; SIGNAL TRANSDUCTION; THYROXINE;

EID: 34548132455     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.04.017     Document Type: Article

References (35)

1. Sommerschild H.T., and Kirkebøen K.A. Adenosine and cardioprotection during ischaemia and reperfusion-an overview. Acta Anaesthesiol Scand 44 (2000) 1038-1055
2. Headrick J.P., Hack B., and Ashton K.J. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol 285 (2003) H1797-H1818
3. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79 (1997) 2-10
4. Szentmiklosi A.J., Nemeth M., Cseppento A., Szegi J., Papp J.G., and Szekeres L. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase. Arch Int Pharmacodyn Ther 256 (1982) 236-252
5. Gesztelyi R., Zsuga J., Bajza A., Cseppento{combining double acute accent} A., Szabó J.Z., and Szentmiklósi A.J. Special sensitization pattern in adenosine-induced myocardial responses after thyroxine treatment. J Pharmacol Sci 91 (2003) 295-304
6. Manthei S.A., Reiling C.M., and Van Wylen D.G. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition. Cardiovasc Res 37 (1998) 171-178
7. Sandhu G.S., Burrier A.C., and Janero D.R. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am J Physiol 265 (1993) H1249-H1256
8. 2) on guinea pig left atria in eu- and hyperthyroidism. Gen Physiol Biophys 22 (2003) 501-513
9. Pavan B., and IJzerman A.P. Processing of adenosine receptor agonists in rat and human whole blood. Biochem Pharmacol 56 (1998) 1625-1632
10. Karsai D., Zsuga J., Juhasz B., Der P., Szentmiklosi A.J., Tosaki A., et al. Effect of nucleoside transport blockade on the interstitial adenosine level characterized by a novel method in guinea pig atria. J Cardiovasc Pharmacol 47 (2006) 103-109. http://www.cardiovascularpharm.com/pt/re/jcardiopharm/fulltext.00005344-200602000-000015.htm Corrected online version available from http://www.cardiovascularpharm.com/pt/re/jcardiopharm/fulltext.00005344-200602000-000015.htm [cited 26 March 2007]
11. Karsai D., Gesztelyi R., Zsuga J., Jakab A., Szendrei L., Juhasz B., et al. Influence of hyperthyroidism on the effect of adenosine transport blockade assessed by a novel method in guinea pig atria. Cell Biochem Biophys 47 (2007) 45-52
12. Kurachi Y., Nakajima T., and Sugimoto T. On the mechanism of activation of muscarinic potassium channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflügers Arch 407 (1986) 264-274
13. Belardinelli L., Shryock J.C., Song Y., Wang D., and Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9 (1995) 359-365
14. Silva P.H., Dillon D., and Van Wylen D.G. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 29 (1995) 616-623
15. Schutz W., Schrader J., and Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol 240 (1981) H963-H970
16. Conant A.R., and Jarvis S.M. Nucleoside transport in guinea-pig myocardium. Adv Exp Med Biol 309A (1991) 415-418
17. Gesztelyi R., Zsuga J., Juhasz B., Der P., Vecsernyes M., and Szentmiklosi A.J. Concentration estimation via curve fitting: quantification of negative inotropic agents by using a simple mathematical method in guinea pig atria. Bull Math Biol 66 (2004) 1439-1453
18. Souza L.F., Horn A.P., Gelain D.P., Jardim F.R., Lenz G., and Bernard E.A. Extracellular inosine modulates ERK 1/2 and p38 phosphorylation in cultured Sertoli cells: possible participation in TNF-alpha modulation of ERK 1/2. Life Sci 77 (2005) 3117-3126
19. Smolenski R.T., Yacoub M.H., and Seymour A.M. Hyperthyroidism increases adenosine transport and metabolism in the rat heart. Mol Cell Biochem 143 (1995) 143-149
20. Rubinstein I., and Binah O. Thyroid hormone modulates membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 340 (1989) 705-711
21. 2+ current in guinea pig ventricular myocytes. Pflugers Arch 421 (1992) 425-430
22. 2+ channels in patients with latent hyperthyroidism. Am J Physiol 278 (2000) H723-H730
23. Arai M., Otsu K., Maclennan D.H., Alpert N.R., and Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res 69 (1991) 266-276
24. Kaasik A., Minajeva A., Paju K., Eimre M., and Seppet E.K. Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles. Mol Cell Biochem 176 (1997) 119-126
25. Shenoy R., Klein I., and Ojamaa K. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am J Physiol 281 (2001) H1690-H1696
26. Szentmiklosi A.J., Cseppento A., Szabo J.Z., Nosztray K., and Szegi J. Myocardial and vascular actions of purinoceptor activators are reduced after thyroxine treatment. Pharmacol Res 25 Suppl 2 (1992) 171-172
27. 1-receptor agonist in rat left atria in hypothyroidism. J Mol Cell Cardiol 26 (1994) 509-517
28. Deussen A. Metabolic flux rates of adenosine in the heart. N-S Arch Pharmacol 362 (2000) 351-363
29. Podzuweit T., Nennstiel P., and Muller A. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl)adenine. Cell Signal 7 (1995) 733-738
30. Ko W.C., Shih C.M., Lai Y.H., Chen J.H., and Huang H.L. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem Pharmacol 68 (2004) 2087-2094
31. Terasaka T., Nakanishi I., Nakamura K., Eikyu Y., Kinoshita T., Nishio N., et al. Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorg Med Chem Lett 13 (2003) 1115-1118 Erratum in Bioorg Med Chem Lett 2003; 13: 4147
32. 1-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells. Br J Pharmacol 130 (2000) 1156-1164
33. i alpha are not associated with changes in their mRNAs. Mol Pharmacol 36 (1989) 681-688
34. Black J.W., and Leff P. Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220 (1983) 141-162
35. Van der Graaf P.H., and Danhof M. Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling. Int J Clin Pharmacol Ther 35 (1997) 442-446